CHICAGO – Drug-induced liver injury, or DILI, doesn't affect a large number of patients on drug therapy, but in clinical practice it disproportionately impedes patient care. When elevated liver enzymes are detected, treating physicians must consider whether DILI is implicated and, if so, which drug is involved, often forcing them to discontinue multiple medications while they investigate the cause.